Strategy
Chris Collins
+8%
By Grow
1 Year Historical Return
This strategy tracks equity positions disclosed in Chris Collins's congressional financial filings submitted within 30 days of each trade. The assets distribution and weights are updated when new filings are posted
Vertex Pharmaceuticals
13%
Enlivex Therapeutics
13%
AbbVie
13%
Pfizer
13%
Regeneron Pharmaceuticals
13%
Amgen
13%
Moderna
13%
Capricor Therapeutics
13%
